Regenerative medicine development based at the Kobe Medical Innovation Center
First written in FY2017. 5 of 7 entries say "Advanced", first in FY2018. Latest entry: FY2025.
1 other company's latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「Furthermore, as a member of the Cultured Meat Future Creation Consortium, in which we are participating, we successfully produced cultured meat samples, which are scheduled to be exhibited at Expo 2025 Osaka, Kansai.」
Research into regenerative medicine and large-scale cell culture advanced to the successful production of cultured meat samples and plans to exhibit them at Expo 2025 Osaka, Kansai. - FY2024AdvancedAnnual report
「In the fields of cell therapy and regenerative medicine, we will continue to promote collaboration with academia and drug-discovery ventures, actively pursue the commercialization of contract cell culture and processing, and support the industrialization and widespread adoption of new modalities.」
The regenerative medicine research advanced from collaboration with universities and ventures to promoting the commercialization and industrialization of contract cell culture and processing. - FY2022AdvancedAnnual report
「Expanding the applications of large-scale cell culture process technology into regenerative medicine and gene therapy and promoting its commercialization」
The scope of the regenerative medicine research became more defined, moving from research on the large-scale culture of human stem cells and other cells to expanding applications in regenerative medicine and gene therapy and promoting commercialization. - FY2021AdvancedAnnual report
「In addition, at the satellite laboratory established inside the Kobe Medical Innovation Center, we are pursuing research and development on the large-scale culture of human stem cells and other cells, which is essential for the industrialization and widespread adoption of regenerative medicine, in collaboration with several university laboratories and regenerative medicine ventures.」
The regenerative medicine research advanced from the initial stage at the satellite laboratory to promoting large-scale culture of human stem cells and other cells with multiple universities and ventures. - FY2019RestatedAnnual report
「In addition, at the satellite laboratory established inside the Kobe Medical Innovation Center, we have begun research and development in the growing field of regenerative medicine.」
Research and development in regenerative medicine continues at the satellite laboratory. - FY2018AdvancedAnnual report
「At the satellite laboratory established inside the Kobe Medical Innovation Center, we have begun research and development in the growing field of regenerative medicine.」
Research and development in regenerative medicine began at the satellite facility. - FY2017First statedAnnual report
「We established a satellite office at the Kobe Medical Innovation Center, a core facility of the Kobe Medical Industry Development Park, and will strengthen development in regenerative medicine, including large-scale cell culture technologies.」
The Company outlined a plan to establish a satellite office and strengthen development in regenerative medicine, including large-scale cell culture technologies.